Advertisement Schering-Plough launches asthma drug inhaler - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Schering-Plough launches asthma drug inhaler

Schering-Plough has announced that Asmanex Twisthaler 110mcg is now available in pharmacies nationwide.

Asmanex is indicated for the maintenance treatment of asthma as prophylactic therapy in patients four years of age and older, and is said to be the first and only once-daily inhaled corticosteroid inhaler approved for this use in children as young as four.

Asmanex was approved for children ages four to 11 by the FDA in February 2008. It is not indicated for the relief of sudden asthma symptoms or in children less than four years of age.